Followers

Sunday, October 16, 2011

Pharma News: Vivus, Anadys, Par

Pharma News: Vivus, Anadys, Par Vivus (VVUS) said today it has resubmitted its new drug application for obesity treatment Qnexa to the US food and Drug Administration. The resubmission follows an agreement reached with an FDA committee seeking approval with a contraindication for ... Pharma News: Vivus, Anadys, Par

No comments:

Post a Comment

Popular Posts